[PDF][PDF] clinical Trial Depleting T Lymphocytes From Donor Marrow for Matched and ismatched Allogeneic Bone Marrow Transplants
A Peterson - Cancer treatment reports, 1985 - researchgate.net
Nine patients received T-lymphocyte-depleted histocompatible bone marrow and 28 paents
received T-lymphocyte-depleted histoincompatible bone marrow. Eight of nine paents
receiving matched bone marrow quickly engrafted without severe graft-versus-host gease
(GvHD). None of the eight patients received anti-GvHD prophylaxis medications. Two of
these eight patients are currently alive. Nonengraftment and severe GvHD were problems
seen in some of the patients given the histoincompatible bone marrow. Additional cytarabine …
received T-lymphocyte-depleted histoincompatible bone marrow. Eight of nine paents
receiving matched bone marrow quickly engrafted without severe graft-versus-host gease
(GvHD). None of the eight patients received anti-GvHD prophylaxis medications. Two of
these eight patients are currently alive. Nonengraftment and severe GvHD were problems
seen in some of the patients given the histoincompatible bone marrow. Additional cytarabine …